Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases

International Journal of Obesity

Volumn 28, Issue SUPPL. 4, 2004, Pages

  Montani, J P ^a   Carroll, J F ^b   Dwyer, T M ^c   Antic, V ^a   Yang, Z ^a   Dulloo, A G ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular diseases; Ectopic fat storage; Hypertension; Lipotoxicity; Perivascular fat; Sinus lipomatosis

Indexed keywords

BLOOD VESSEL; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; HEART; HUMAN; HYPERTENSION; KIDNEY; KIDNEY BLOOD FLOW; LIPID STORAGE; PARACRINE SIGNALING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SODIUM ABSORPTION; SYSTOLIC BLOOD PRESSURE; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CHORISTOMA; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; LIPID METABOLISM; LIPOMATOSIS; MODELS, BIOLOGICAL; MYOCARDIUM; OBESITY;

ANIMALIA;

EID: 12444318666     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802858     Document Type: Conference Paper

References (66)

1. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001; 15: 312-321.
2. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14: 281-287.
3. Carroll JF, Huang M, Hester RL, Cockrell K, Mizelle HL. Hemodynamic alterations in hypertensive obese rabbits. Hypertension 1995; 26: 465-470.
4. Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, Meydrech EF, Mizelle HL. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol 1996; 271: H373-H378.
5. Carroll JF, Summers RL, Dzielak DJ, Cockrell K, Montani JP, Mizelle HL. Diastolic compliance is reduced in obese rabbits. Hypertension 1999; 33: 811-815.
6. Antic V, Tempini A, Montani JP. Serial changes in cardiovascular and renal function of rabbits ingesting a high-fat, high-calorie diet. Am J Hypertens 1999; 12: 826-829.
7. Antic V, Kiener-Belforti F, Tempini A, Van Vliet BN, Montani JP. Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits. Am J Hypertens 2000; 13: 556-559.
8. Antic V, Van Vliet BN, Montani JP. Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits. Auton Neurosci 2001; 90: 152-157.
9. Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord 1995; 19: 869-874.
10. Carroll JF, Braden DS, Cockrell K, Mizelle HL. Obese hypertensive rabbits develop concentric and eccentric hypertrophy and diastolic filling abnormalities. Am J Hypertens 1997; 10: 230-233.
11. Hall JE, Brands MW, Dixon WN, Smith Jr MJ. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993; 22: 292-299.
12. Mizelle HL, Edwards TC, Montani JP. Abnormal cardiovascular responses to exercise during the development of obesity in dogs. Am J Hypertens 1994; 7: 374-378.
13. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991; 68: 1713-1721.
14. Carroll JF, Jones AE, Hester RL, Reinhart GA, Cockrell K, Mizelle HL. Reduced cardiac contractile responsiveness to isoproterenol in obese rabbits. Hypertension 1997; 30: 1376-1381.
15. Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S28-S38.
16. Scaglione R, Dichiara MA, Indovina A, Lipari R, Ganguzza A, Parrinello G, Capuana G, Merlino G, Licata G. Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 1992; 13: 738-742.
17. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
18. van Duijnhoven EC, Cheriex EC, Tordoir JH, Kooman JP, van Hooff JP. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant 2001; 16: 368-372.
19. Van Vliet BN, Montani JP. Baroreflex stabilization of the double product. Am J Physiol 1999; 277: H1679-H1689.
20. Van Vliet BN, Belforti F, Montani JP. Baroreflex stabilization of the double (pressure-rate) product at 0.05 Hz in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1746-R1753.
21. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith Jr MJ. Reduced parasympathetic control of heart rate in obese dogs. Am J Physiol 1995; 269: H629-H637.
22. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784-1789.
23. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB, Nielsen LB. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003; 144: 3483-3490.
24. Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 2001; 25: 378-388.
25. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003; 49: 417-423.
26. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
27. Fonarow GC, Horwich TB. Prevention of heart failure: effective strategies to combat the growing epidemic. Rev Cardiovasc Med 2003; 4: 8-17.
28. Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 1991; 13: 277-296.
29. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16: 1057-1063.
30. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44: 271-276.
31. Henrichot E, Juge-Aubry CE, Wohlwend A, Somm E, Pernin A, Pauchot J, Giusti V, Dayer JM, Chizzolini C, Meier CA. Production of IP-10 and RANTES by human adipose tissue: a role for perivascular adipocytes in atherosclerosis? [abstract]. Annual Meeting of the Endocrine Society 2004, OR-34-6.
32. Barandier C, Yang Z. Adipocytes release a heat- and trypsin-resistant growth factor for vascular smooth muscle cells: effects of obesity and aging [abstract]. European Society of Cardiology Congress 2004; P374.
33. Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese vs lean adults. Am J Cardiol 2003; 91: 195-199.
34. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003; 42: 468-473.
35. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358: 1400-1404.
36. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003; 27 (Suppl 3): S25-S28.
37. Tertov VV, Orekhov AN, Martsenyuk ON, Perova NV, Smirnov VN. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol 1989; 50: 337-347.
38. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047-1052.
39. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma AM. The adipose-tissue renin-angiotensin- aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-825.
40. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 2002; 15: 381-388.
41. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47: 141-150.
42. Singhal A, Farooqi IS, Cole TJ, O'Rahilly S, Fewtrell M, Kattenhorn M, Lucas A, Deanfield J. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002; 106: 1919-1924.
43. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 554-558.
44. Schafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004; 24: 112-117.
45. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
46. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14: 561-566.
47. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893-2898.
48. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
49. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
50. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13.
51. Schecter AD, Berman AB, Taubman MB. Chemokine receptors in vascular smooth muscle. Microcirculation 2003; 10: 265-272.
52. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932.
53. Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiott KM, Fain JN, Richelsen B. Higher production of IL-8 in visceral vs subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004; 286: E8-E13.
54. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 2004; 94: 253-261.
55. Gerszten RE, Mach F, Sauty A, Rosenzweig A, Luster AD. Chemokines, leukocytes, and atherosclerosis. J Lab Clin Med 2000; 136: 87-92.
56. Granger JP, West D, Scott J. Abnormal pressure natriuresis in the dog model of obesity-induced hypertension. Hypertension 1994; 23: 18-11.
57. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10: 49S-55S.
58. Kaissling B, Kriz W. Structural analysis of the rabbit kidney. Adv Anat Embryol Cell Biol 1979; 56: 1-123.
59. Knepper MA, Saidel GM, Hascall VC, Dwyer T. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer. Am J Physiol Renal Physiol 2003; 284: F433-F446.
60. Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner renal medulla of obese dogs. Hypertension 1995; 25: 888-892.
61. Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int 2000; 58: 721-729.
62. Ott CE, Navar LG, Guyton AC. Pressures in static and dynamic states from capsules implanted in the kidney. Am J Physiol 1971; 221: 394-400.
63. Burnett Jr JC, Knox FG. Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol 1980; 238: F279-F282.
64. Burnett Jr JC, Haas JA, Knox FG. Segmental analysis of sodium reabsorption during renal vein constriction. Am J Physiol 1982; 243: F19-F22.
65. Stolarczyk J, Carone FA. Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol 1975; 78: 285-296.
66. Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med 1997; 241: 71-79.